UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 363

Sortiert nach

A Comprehensive Algorithm for Management of Neuropathic Pain

Pain medicine (Malden, Mass.), 2019-06, Vol.20 (Supplement_1), p.S2-S12

2019

Link zum Volltext

Verfügbarkeit prüfen

Gemcitabine combined with the monoclonal antibody nimotuzumab is an active first-line regimen in KRAS wildtype patients with locally advanced or metastatic pancreatic cancer: a multicenter, randomized phase IIb study

Annals of oncology, 2017-10, Vol.28 (10), p.2429

2017

Link zum Volltext

Verfügbarkeit prüfen

Neuromodulation of the Dorsal Root Ganglion for Chronic Postsurgical Pain

Pain medicine (Malden, Mass.), 2019-06, Vol.20 (Supplement_1), p.S41-S46

2019

Link zum Volltext

Verfügbarkeit prüfen

Regorafenib (BAY 73-4506) in advanced colorectal cancer: a phase I study

British journal of cancer, 2012-05, Vol.106 (11), p.1722-1727

2012

Link zum Volltext

Verfügbarkeit prüfen

High activity of sorafenib in FLT3-ITD-positive acute myeloid leukemia synergizes with allo-immune effects to induce sustained responses

Leukemia, 2012-11, Vol.26 (11), p.2353-2359

2012

Link zum Volltext

Verfügbarkeit prüfen

Regorafenib in combination with FOLFOX or FOLFIRI as first- or second-line treatment of colorectal cancer: results of a multicenter, phase Ib study

Annals of oncology, 2013-06, Vol.24 (6), p.1560-1567

2013

Link zum Volltext

Verfügbarkeit prüfen

Synergistic activity of imatinib and 17-AAG in imatinib-resistant CML cells overexpressing BCR-ABL - Inhibition of P-glycoprotein function by 17-AAG

Leukemia, 2005-07, Vol.19 (7), p.1198-1206

2005

Link zum Volltext

Verfügbarkeit prüfen

Selection and characterization of BCR-ABL positive cell lines with differential sensitivity to the tyrosine kinase inhibitor STI571: diverse mechanisms of resistance

Blood, 2000-08, Vol.96 (3), p.1070-1079

2000

Link zum Volltext

Verfügbarkeit prüfen

High dose ara-C in the treatment of newly diagnosed acute promyelocytic leukemia: long-term results of the German AMLCG

Leukemia, 2009-12, Vol.23 (12), p.2248-2258

2009

Link zum Volltext

Verfügbarkeit prüfen

Aspergillus PCR-Based Investigation of Fresh Tissue and Effusion Samples in Patients with Suspected Invasive Aspergillosis Enhances Diagnostic Capabilities

Journal of Clinical Microbiology, 2013-12, Vol.51 (12), p.4178-4185

2013

Link zum Volltext

Verfügbarkeit prüfen

Combination of sorafenib and doxorubicin in patients with advanced hepatocellular carcinoma: Results from a phase I extension trial

European journal of cancer (1990), 2009-03, Vol.45 (4), p.579-587

2009

Link zum Volltext

Verfügbarkeit prüfen

Stable RNA interference (RNAi) as an option for anti-bcr-abl therapy

Gene therapy, 2005-01, Vol.12 (1), p.12-21

2005

Link zum Volltext

Verfügbarkeit prüfen

Diagnostic accuracy of cytology and immunocytology in carcinomatous effusions

Cytopathology (Oxford), 2008-08, Vol.19 (4), p.205-211

2008

Link zum Volltext

Verfügbarkeit prüfen

Phase IB study of sorafenib in combination with gemcitabine and cisplatin in patients with refractory solid tumors

Cancer chemotherapy and pharmacology, 2012-02, Vol.69 (2), p.333-339

2012

Link zum Volltext

Verfügbarkeit prüfen

Arsenic trioxide: "a successful poison" in patients with acute promyelocytic leukemia

Deutsche medizinische Wochenschrift, 2007-02, Vol.132 (7), p.330

2007

Link zum Volltext

Verfügbarkeit prüfen

Arsentrioxid: „ein erfolgreiches Gift” bei Patienten mit akuter Promyelozytenleukämie

Deutsche medizinische Wochenschrift, 2007-02, Vol.132 (7), p.330-336

2007

Link zum Volltext

Verfügbarkeit prüfen

Successful sequential antiangiogenic therapy for alveolar soft part sarcoma - a case report

International journal of clinical pharmacology and therapeutics, 2010-07, Vol.48 (7), p.468

2010

Link zum Volltext

Verfügbarkeit prüfen

Phase I dose escalation study of telatinib (BAY 57-9352) in patients with advanced solid tumours

British journal of cancer, 2008-11, Vol.99 (10), p.1579-1585

2008

Link zum Volltext

Verfügbarkeit prüfen

BCR-ABL with an e6a2 fusion in a CML patient diagnosed in blast crisis

Leukemia, 2003-10, Vol.17 (10), p.2054-2055

2003

Link zum Volltext

Verfügbarkeit prüfen

Imatinib sensitivity as a consequence of a CSF1R-Y571D mutation and CSF1 CSF1R signaling abnormalities in the cell line GDM1

Leukemia, 2009-02, Vol.23 (2), p.358-364

2009

Link zum Volltext

Verfügbarkeit prüfen

e8a2 BCR-ABL: more frequent than other atypical BCR-ABL variants?

Leukemia, 2005-04, Vol.19 (4), p.681-684

2005

Link zum Volltext

Verfügbarkeit prüfen

Safety, efficacy and pharmacokinetics of nimotuzumab, a humanized monoclonal anti-epidermal growth factor receptor (EGFR) antibody, in patients with locally advanced or metastatic pancreatic cancer

International journal of clinical pharmacology and therapeutics, 2010-07, Vol.48 (7), p.473

2010

Link zum Volltext

Verfügbarkeit prüfen

Alterations of the cyclin D1/pRb/p16(INK4A) pathway in multiple myeloma

Leukemia, 2002-09, Vol.16 (9), p.1844-1851

2002

Link zum Volltext

Verfügbarkeit prüfen

Capecitabine in combination with docetaxel and mitomycin C in patients with pre-treated tumours: results of an extended phase-I trial

British journal of cancer, 2007-12, Vol.97 (11), p.1475-1479

2007

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 363

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(334)
Mit Volltextzugriff
(347)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(235)
Physical Sciences
(120)
Life Sciences & Biomedicine
(114)
Astronomy & Astrophysics
(101)
Humans
(85)
Astrophysics
(81)
Physics
(63)
Biological And Medical Sciences
(43)
Female
(41)
Oncology
(38)
Male
(36)
Astronomi, Astrofysik Och Kosmologi
(35)
Astronomy, Astrophysics And Cosmology
(35)
Fysik
(35)
Natural Sciences
(35)
Naturvetenskap
(35)
Stars: Abundances
(35)
Sciences Of The Universe
(32)
Animals
(31)
Medical Sciences
(31)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

A Comprehensive Algorithm for Management of Neuropathic Pain

Gemcitabine combined with the monoclonal antibody nimotuzumab is an active first-line regimen in KRAS wildtype patients with locally advanced or metastatic pancreatic cancer: a multicenter, randomized phase IIb study

Neuromodulation of the Dorsal Root Ganglion for Chronic Postsurgical Pain

Regorafenib (BAY 73-4506) in advanced colorectal cancer: a phase I study

High activity of sorafenib in FLT3-ITD-positive acute myeloid leukemia synergizes with allo-immune effects to induce sustained responses

Regorafenib in combination with FOLFOX or FOLFIRI as first- or second-line treatment of colorectal cancer: results of a multicenter, phase Ib study

Synergistic activity of imatinib and 17-AAG in imatinib-resistant CML cells overexpressing BCR-ABL - Inhibition of P-glycoprotein function by 17-AAG

Selection and characterization of BCR-ABL positive cell lines with differential sensitivity to the tyrosine kinase inhibitor STI571: diverse mechanisms of resistance

High dose ara-C in the treatment of newly diagnosed acute promyelocytic leukemia: long-term results of the German AMLCG

Aspergillus PCR-Based Investigation of Fresh Tissue and Effusion Samples in Patients with Suspected Invasive Aspergillosis Enhances Diagnostic Capabilities

Combination of sorafenib and doxorubicin in patients with advanced hepatocellular carcinoma: Results from a phase I extension trial

Stable RNA interference (RNAi) as an option for anti-bcr-abl therapy

Diagnostic accuracy of cytology and immunocytology in carcinomatous effusions

Phase IB study of sorafenib in combination with gemcitabine and cisplatin in patients with refractory solid tumors

Arsenic trioxide: "a successful poison" in patients with acute promyelocytic leukemia

Arsentrioxid: „ein erfolgreiches Gift” bei Patienten mit akuter Promyelozytenleukämie

Successful sequential antiangiogenic therapy for alveolar soft part sarcoma - a case report

Phase I dose escalation study of telatinib (BAY 57-9352) in patients with advanced solid tumours

BCR-ABL with an e6a2 fusion in a CML patient diagnosed in blast crisis

Imatinib sensitivity as a consequence of a CSF1R-Y571D mutation and CSF1 CSF1R signaling abnormalities in the cell line GDM1

e8a2 BCR-ABL: more frequent than other atypical BCR-ABL variants?

Safety, efficacy and pharmacokinetics of nimotuzumab, a humanized monoclonal anti-epidermal growth factor receptor (EGFR) antibody, in patients with locally advanced or metastatic pancreatic cancer

Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders

Alterations of the cyclin D1/pRb/p16(INK4A) pathway in multiple myeloma

Capecitabine in combination with docetaxel and mitomycin C in patients with pre-treated tumours: results of an extended phase-I trial

Suchergebnisse filtern